Home
Search
BIO Investor Forum    |   October 15-16, 2024

Speakers & Presenters

All Speakers
All Speakers
Filter by letter
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
photo
Jonathan Baker, PHD
SENIOR TECHNOLOGY MANAGER, MONTANA BIOSCIENCE ALLIANCE
TechLink/Department of Veterans Affairs/Department of Defense
Bozeman, Montana, United States
photo
Jianxin Bao, PHD
CEO, GATEWAY BIOTECHNOLOGY INC.
Gateway Biotechnology
Saint Louis, Missouri, United States
photo
Dror Bashan
PRESIDENT & CEO, PROTALIX BIOTHERAPEUTICS
Protalix BioTherapeutics
Karmiel, Israel
photo
Piraye Beim, PHD
CHIEF EXECUTIVE OFFICER, CELMATIX, INC.
Celmatix
New York, New York, United States
photo
Abhijit Bhatia, MBA, MS
VICE PRESIDENT OF GLOBAL CORPORATE & BUSINESS DEVELOPMENT, RAKUTEN MEDICAL, INC.
Rakuten Medical
San Diego, California, United States
photo
Barbara Bierer
FACULTY DIRECTOR, MRCT CENTER OF HARVARD AND BWH
Addressing Racism and Disparities during Therapeutic Development and in the Clinic
Cambridge, Massachusetts, United States
photo
Igor Bilinsky, PHD
CHIEF BUSINESS OFFICER, ONCTERNAL THERAPEUTICS
Oncternal Therapeutics
San Diego, California, United States
photo
Montserrat Biosca
CEO, NANOLIGENT SL
Nanoligent SL
Bellaterra (Barcelona), Spain
photo
Greg Bosch, MBA
CHIEF EXECUTIVE OFFICER, GEISTLICH PHARMA NORTH AMERICA, INC
Geistlich Pharma
Princeton, New Jersey, United States
photo
Martin Bott
INTERIM GENERAL MANAGER, AMR ACTION FUND
The New AMR Action Fund to Invest in Antibiotic Development
Carmel, Indiana, United States
photo
Janice Bourque, MBA
MANAGING DIRECTOR, HERCULES CAPITAL
Market Outlook: Solid Ground or Thin Ice?
Boston, Massachusetts, United States
photo
Melissa Bradford-Klug
CHIEF BUSINESS OFFICER, CITRINE MEDICINE
China Deal-Making Now: New Opportunities and Barriers
Cambridge, Massachusetts, United States
photo
Christopher Bradley, MSC
CEO, LOKI THERAPEUTICS
Loki Therapeutics
Long Island City, New York, United States
photo
Ross Breckenridge, PHD, MD
CEO, ARJUNA THERAPEUTICS
ARJUNA Therapeutics
Santiago de Compostela, Spain
photo
Paul Brennan, MSC, BSC
PRESIDENT & CEO, NERVGEN PHARMA
NervGen Pharma Corp.
Vancouver, British Columbia, Canada
photo
Rod Bugawan
BUSINESS DEVELOPMENT MANAGER, NOVOTECH (AUSTRALIA) PTY LIMITED
Novotech
San Francisco, California, United States
Load More